“showed a trend”

found that patients with colorectal cancer with ≥5 CTCs showed a trend toward poor OS and PFS and frequent vascular invasion ( p = 0.035) [ 33 ].

Creatinine showed a trend to higher values among obese patients vs. overweight and normal individuals (KW = 6.72; p = 0.035), but not when patients with ascites were excluded (KW = 5.83; p = 0.054); moreover, logistic regression analysis showed that the only variable related to obesity was sclerostin ( p = 0.023).

Only endometrioid histology compared with non-endometrioid histology showed a trend to better OS (HR = 0.09, P = 0.035) (Table 2 ).

Dunn’s post hoc test revealed that the Shannon diversity was significantly higher, and Chao1 species richness indices showed a trend toward higher in PN samples than in PD samples (adjusted p = 0.0358 and 0.0598, respectively).

Of note, although rs10484561 showed a trend towards association in DLBCL in SF1 (trend p -value=3.58×10 -2 ), we did not observe markedly significant associations between the MHC region with risk of CLL/SLL or DLBCL ( Supplementary Fig. 5 ), which suggests that the influence of MHC genetic variation differs by NHL subtype.

At day 37, only body length significantly differed across canopy types ( p < .001), although tail depth also showed a trend for differences across canopy type ( p < .036; Table S2 ).

The patients in the experimental group also showed a trend of decreasing TBil levels when compared with patients in the control group ( p = 0.036).

In multivariate Cox regression analysis, including age, histological grade, tumor size and lymph node status, the macroH2A1.1/macroH2A1 mRNA ratio showed a trend as an independent predictor (HR 3.457, 95%CI 1.087 to 10.990, p = 0.036 ) ( Fig.5B ).

In the advanced-stage diseases, low cytoplasmic phospho-p38 was significantly associated with present residual tumor and showed a trend toward stage IV disease ( p =0.036 and 0.073, respectively; Table 4 ).

Runners with the D polymorphism (I/D and D/D) showed a trend of better performance in the 100-km ultra-marathon (measured by completion time in minutes, P = .036).

Hence, the comparison between the PPMS and SPMS showed a trend similar to the differences observed between the controls and PPMS groups for Mg, Cu, and Pb ( p = 0.036, 0.03, and 0.34, respectively).

In figure 4 c , co-registered measurements from the region of the fibrous cap ( n = 24) within diseased tissue sections were added to the dataset of the healthy group ( figure 3 ) which showed a trend towards a positive correlation between Young's modulus and collagen fibre density (Pearson's ρ = 0.53, p = 0.036).

Notably, the posterior group showed a trend of lateral foot pressure surpassing the ACDF group at 2 years (59.47% vs. 58.15%, P = 0.036).

Treatment with carboplatin and paclitaxel showed a trend towards increasing the risk of complications (OR=1.926, 95% CI: 1.045–3.551, P=0.036).

Atp1a3 +/D801Y males showed a trend to lower weights only above 4 months of age; linear regression analysis found a significant difference ( p = 0.036; Fig. 1 B ).

Within the opioid-FM group, higher pain sensitivity to heat (i.e., lower sensitivity-adjusted temperatures) showed a trend relationship with higher opioid dosage ( r = −0.45, p = 0.036), potentially reflective of opioid-related hyperalgesia.

At age 3 months, microglia of rTg4510 mice showed a trend toward decreases in Mmp2 (p = 0.0363) and Mmp9 (p = 0.0124) mRNA levels and an increase in Mmp14 mRNA level (p = 0.0341) compared to non-Tg mice as examined by Student’s t test with Bonferroni’s correction (N = three mice in each genotype; Figure 5 E).

Before PSM, radiotherapy showed a trend toward white race ( p = 0.037), high grade ( p = 0.017), large tumor size ( p = 0.010), positive nodal metastasis ( p = 0.021), advanced stage ( p < 0.001) and chemotherapy ( p = 0.008) ( Table 3 ).

The Jonckheere–Terpstra test showed a trend toward decreasing OT with calendar year on the left side ( p = 0.037) (surgeon’s non-dominant side), but not on the right ( p = 0.795).

Additionally, hormone replacement therapy use showed a trend toward better delayed recall performance ( β = .58, SE = .27, p = .037, FDR-corrected p = .495), suggesting potential cognitive benefits.

The relative, AR modeled VLF showed a trend toward significant divergence between cohorts (ANOVA q = 0.142), potentially driven by the comparison of controls to CKD/T2DM patients (adj. p = 0.037, Supplementary Table S7 ).

Participants in the Q3 also showed a trend toward risk reduction (OR 0.57, 95% CI 0.34–0.97, p = 0.037).

ARHGEF18 showed a nominally significant downregulation (i.e., higher Ct values) in cases ( p = 0.037), and SRXN1 showed a trend towards downregulation in cases ( p = 0.056) compared with the combined control group.

A total of 144 patients were eligible for radiomic analysis, and two grey-level zone-length matrix derived parameters obtained from the iliac crests showed a trend for higher values in the BMBx-positive group compared to the BMBx-negative group (mean 436.6 ± 449.0 versus 227.2 ± 137.8, unadjusted p = 0.037 for high grey-level zone emphasis; mean 308.8 ± 394.4 versus 135.7 ± 97.2, unadjusted p = 0.048 for short-zone high grey-level emphasis), but statistical significance was not found after multiple comparison correction.

Compared with healthy controls (median 5.99 AU), AGEs showed a trend in impaired glucose tolerance (7.22 AU; Cohen’s d = 0.425; uncorrected p = .037, corrected p = .094), significant increases in uncomplicated diabetes (9.81 AU; d = 1.027, p < .001) and complicated diabetes (13.35 AU; d = 1.540, p < .001), with no elevation in isolated hyperlipidaemia (5.86 AU; p = .987).